COVID-19 a Reminder of the Challenge of Emerging Infectious Diseases
Given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States.
Read MorePosted by Steve Halasey | Mar 4, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States.
Read MorePosted by | Feb 28, 2020 | Cancer, Molecular Diagnostics |
The comarketing partnership is intended to drive awareness of ArcherDx diagnostic products and increase access to vital genomic information in community oncology care settings.
Read MorePosted by | Feb 25, 2020 | Immunoassay, Immunoassay Instrumentation, Immunoassay Reagents & test Kits, Rapid Assays |
The Bill and Melinda Gates Foundation has granted the partners $885,000 to develop an advanced rapid diagnostic for onchocerciasis.
Read MorePosted by | Feb 21, 2020 | Flu & Respiratory Infections, Infectious Diseases |
The panel test detects Pneumocystis jirovecii in addition to a broad spectrum of clinically relevant bacterial pathogens and antibiotic-resistance markers associated with pneumonia.
Read MorePosted by Steve Halasey | Feb 19, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The structure of the SARS-CoV-2 spike is similar to that of the coronavirus responsible for the 2003 global outbreak of severe acute respiratory syndrome.
Read More